---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-233427"
form_type: "8-K"
ticker: "ACET"
cik: "0001720580"
company_name: "Adicet Bio, Inc."
filed_at: "2025-10-07T23:59:59+00:00"
generated_at: "2026-05-17T04:27:55.350542+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Adicet Bio granted 180-day Nasdaq extension; transferred to Capital Market

## Summary
- Extension until April 6, 2026 to regain $1.00 minimum bid price; transferred to Nasdaq Capital Market effective Oct 9, 2025.
- Company may consider reverse stock split to meet bid price requirement; if not regained, Nasdaq will issue delisting notice.
- Previous 180-day compliance period ended Oct 6, 2025; extension granted Oct 7, 2025.
- No immediate impact on common stock listing; ACET continues trading under symbol ACET.

## SEC filing metadata
- accession: 0001193125-25-233427
- form_type: 8-K
- ticker: ACET
- cik: 0001720580
- company_name: Adicet Bio, Inc.
- filed_at: 2025-10-07T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1720580/000119312525233427/0001193125-25-233427-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1720580/000119312525233427/acet-20251007.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-233427
- JSON: https://secwatch.observer/filing/0001193125-25-233427.json
- Plain text: https://secwatch.observer/filing/0001193125-25-233427.txt

## Source-grounded claims
- claim_id: a16a099b7102d8204337539302f805eed28f16c1
  claim: Adicet Bio, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1), 5550(a)(2), 5810(c)(3)(A)).
  evidence_excerpt: October 7, 2025, the Company received a notice (the Extension Notice) from Nasdaq informing the Company that Nasdaq has granted the Company an additional 180 calendar days, or until April 6, 2026, to regain compliance with the Bid Price Requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). In connection with the Extension Notice, the listing of the Common Stock will be transferred from the Nasdaq Global Market to the Nasdaq Capital Market, effective at the opening of business on October 9, 2025. The Extension Notice has no other immediate effect o
  evidence_url: https://www.sec.gov/Archives/edgar/data/1720580/000119312525233427/0001193125-25-233427-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.